Although sales of tobacco products have been restricted in hundreds of municipalities across the US, a new study is ...
Global health is likely to be radically altered with Donald Trump in the White House. For starters, the president-elect has ...
The agency authorized Novavax to start a Phase 3 trial of its combination shot after the company “satisfactorily” addressed ...
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
Former host of the “Rush Limbaugh Show” James Golden, aka Bo Snerdley, discusses why he believes President-elect Donald Trump ...
Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...
Doctors have been fairly quick to jump on the biologics train: According to Spherix, 96% of dermatologists reported using ...
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...
Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl, a late entry to the heated CD19 CAR-T cell therapy ...
FDA Forces Costco To Recall 80,000 Pounds of Butter Because Packaging Did Not Say It ‘Contains Milk’
Costco is being forced to recall 80,000 pounds of butter in Texas because the packaging does not state it includes the base ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
As part of the process, the company will be conducting an ‘End-of-Phase 2’ meeting with the FDA later this month to get input from the agency on their proposed trial design. The study is likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback